1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H2, 2014

Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H2, 2014" provides data on the Respiratory Syncytial Virus (RSV) Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Respiratory Syncytial Virus (RSV) Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Respiratory Syncytial Virus (RSV) Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 7
Respiratory Syncytial Virus (RSV) Infections 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of Respiratory Syncytial Virus (RSV) Infections 26
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Respiratory Syncytial Virus (RSV) Infections 33
Nov 11, 2014: Preclinical Data For GenVec's RSV Vaccine Candidate Presented At The 9th RSV Symposium 33
Nov 10, 2014: ADMA Biologics To Present At The 9th International Respiratory Syncytial Virus Symposium 33
Nov 10, 2014: Novavax Initiates Phase 1 Clinical Trial of RSV F Vaccine in Pediatric Subjects 34
Nov 06, 2014: Ablynx To Present Pre-Clinical Proof-Of-Concept Results With Anti-Rsv Nanobody, ALX-0171, At 9th International Respiratory Syncytial Virus Symposium 34
Oct 26, 2014: Novavax Presents RSV F Protein Nanoparticle Vaccine Clinical Data at the 8th Vaccine and ISV Congress in Philadelphia 35
Oct 20, 2014: Mucosis Presents Data on Intranasal RSV Vaccine SynGEM at Vaccines 2014 Conference 35
Oct 14, 2014: Novavax Initiates Phase 2 Clinical Trial of RSV Vaccine in Elderly Subjects 36
Oct 13, 2014: Alios BioPharma Presented Positive Results of Its Anti-RSV Nucleoside Analog AL-8176 in a Phase 2 Challenge Study in Adults Infected With Respiratory Syncytial Virus (RSV) at IDWeek 36
Sep 16, 2014: Novavax Initiates Phase 2 Clinical Trial of RSV F-Protein Nanoparticle Vaccine Candidate in Healthy Third-Trimester Pregnant Women 37
Sep 08, 2014: Immunization of Pregnant Baboons With the RSV F Nanoparticle Vaccine Protects Infant Baboons Challenged With Respiratory Syncytial Virus in a Comparable Manner to Infants Prophylaxed With Palivizumab 38
Sep 06, 2014: Novavax Presents Data on RSV F Nanoparticle Vaccine Induced Monoclonal Antibody at ICAAC 38
Sep 04, 2014: Biota to Present Preclinical Data on RSV Compound BTA-C585 at ICAAC Meeting 39
Clinical Trial Profiles 40
Clinical Trial Overview of Top Companies 40
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
Novavax, Inc. 43
Clinical Trial Overview of Novavax, Inc. 43
GlaxoSmithKline plc 44
Clinical Trial Overview of GlaxoSmithKline plc 44
Gilead Sciences, Inc. 45
Clinical Trial Overview of Gilead Sciences, Inc. 45
AbbVie Inc. 46
Clinical Trial Overview of AbbVie Inc. 46
Abbott Laboratories 47
Clinical Trial Overview of Abbott Laboratories 47
Johnson and Johnson 48
Clinical Trial Overview of Johnson and Johnson 48
Alnylam Pharmaceuticals, Inc. 49
Clinical Trial Overview of Alnylam Pharmaceuticals, Inc. 49
Novartis AG 50
Clinical Trial Overview of Novartis AG 50
Ablynx NV 51
Clinical Trial Overview of Ablynx NV 51
Clinical Trial Overview of Top Institutes / Government 52
The National Institute of Allergy and Infectious Diseases 52
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 52
University of Texas M. D. Anderson Cancer Center 53
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 53
VU University Medical Center 54
Clinical Trial Overview of VU University Medical Center 54
Rambam Health Care Campus 55
Clinical Trial Overview of Rambam Health Care Campus 55
Fred Hutchinson Cancer Research Center 56
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 56
University Hospitals of Leicester NHS Trust 57
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 57
Imperial College London 58
Clinical Trial Overview of Imperial College London 58
Ziv Medical Center 59
Clinical Trial Overview of Ziv Medical Center 59
Sunnybrook Health Sciences Centre 60
Clinical Trial Overview of Sunnybrook Health Sciences Centre 60
Indiana University School of Medicine 61
Clinical Trial Overview of Indiana University School of Medicine 61
Five Key Clinical Profiles 62
Appendix 103
Abbreviations 103
Definitions 103
Research Methodology 104
Secondary Research 104
About GlobalData 105
Contact Us 105
Disclaimer 105
Source 105

List of Tables

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Region, 2014* 8
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 9
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 10
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 11
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 12
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, North America, Top Countries, 2014* 13
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 14
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 15
Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 16
Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 17
Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 18
Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 19
Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 20
Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 21
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Phase, 2014* 22
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 23
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 24
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 25
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Suspended Clinical Trials, 2014* 26
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Respiratory Syncytial Virus (RSV) Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 40
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novavax, Inc., 2014* 43
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 44
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 45
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014* 46
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 47
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 48
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Alnylam Pharmaceuticals, Inc., 2014* 49
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 50
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Ablynx NV, 2014* 51
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 52
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2014* 53
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2014* 54
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2014* 55
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 56
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2014* 57
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014* 58
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Ziv Medical Center, 2014* 59
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2014* 60
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2014* 61

List of Figures

Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Region (%), 2014* 8
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 9
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 10
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 11
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 12
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 13
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 14
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 15
Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 16
Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 17
Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 18
Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 19
Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 20
Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 21
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014* 22
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 23
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 24
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 25
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Respiratory Syncytial Virus (RSV) Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 104

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.